BACKGROUND Recent clinical trials have suggested that therapy with angiotensin-
converting enzyme inhibitors in asymptomatic patients with reduced left ventricular (LV) …

BACKGROUND Patients with heart failure and reduced left ventricular (LV) ejection fraction
(EF) manifest progressive LV dilatation, which is prevented by angiotensin converting …

BACKGROUND In patients with heart failure, activation of the renin-angiotensin system is
common and has been postulated to provide a stimulus for further left ventricular (LV) …

The prevention or attenuation of the development of heart failure by the angiotensin
converting enzyme inhibitor captopril was examined in two animal models, spontaneously …

BACKGROUND The aim of the present study was to analyze the changes in left ventricular
diastolic function that occur in patients with chronic severe left ventricular systolic …

Background. It is not known whether the treatment of patients with asymptomatic left
ventricular dysfunction reduces mortality and morbidity. We studied the effect of an …

Objectives. This study sought determine the effects of long-term angiotensin-converting
enzyme (ACE) inhibition on left ventricular (LV) diastolic filling in postinfarction heart failure …

Vasodilating drugs such as angiotensin converting enzyme (ACE) inhibitors may extend life
expectancy in patients with congestive heart failure (CHF). The purpose of this study was to …

Objectives. This study was designed to assess the effect of angiotensin-converting enzyme
inhibition and beta-adrenoreceptor blockade on established ventricular remodeling …

Background. Left ventricular dilatation and dysfunction after myocardial infarction are major
predictors of death. In experimental and clinical studies, long-term therapy with the …